GlaxoSmithKline Pharmaceuticals informs about analyst meet

03 Feb 2026 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that an analyst meeting is scheduled on 9th February 2026.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2468.75 25.65 (1.05%)
06-Feb-2026 14:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.80
Dr. Reddys Lab 1235.60
Cipla 1325.25
Zydus Lifesciences 886.30
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×